Rockefeller Capital Management
MYGN icon

Rockefeller Capital Management’s Myriad Genetics MYGN Stock Holding History

Rockefeller Capital Management’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.79K Sell
838
-2,285
-73% -$10.4K ﹤0.01% 4254
2026
Q1 		$14.1K Buy
3,123
+1,941
+164% +$10.1K ﹤0.01% 3854
2025
Q4 		$7.27K Buy
1,182
+207
+21% +$1.5K ﹤0.01% 3938
2025
Q3 		$7.05K Buy
+975
New +$5.79K ﹤0.01% 3772
2023
Q1 		– Sell
-973
Closed -$14K – 3183
2022
Q4 		$14K Sell
973
-218
-18% -$4.06K ﹤0.01% 2933
2022
Q3 		$22K Buy
1,191
+97
+9% +$2.23K ﹤0.01% 2731
2022
Q2 		$19K Sell
1,094
-93
-8% -$1.93K ﹤0.01% 2780
2022
Q1 		$29K Buy
1,187
+497
+72% +$12.7K ﹤0.01% 2568
2021
Q4 		$19K Sell
690
-548
-44% -$15.9K ﹤0.01% 2671
2021
Q3 		$39K Buy
1,238
+838
+210% +$27.8K ﹤0.01% 2259
2021
Q2 		$12K Sell
400
-345
-46% -$9.97K ﹤0.01% 2708
2021
Q1 		$22K Buy
745
+345
+86% +$9.79K ﹤0.01% 2240
2020
Q4 		$7K Sell
400
-95
-19% -$1.53K ﹤0.01% 2342
2020
Q3 		$6K Buy
495
+100
+25% +$1.27K ﹤0.01% 2162
2020
Q2 		$4K Sell
395
-472
-54% -$6.7K ﹤0.01% 2167
2020
Q1 		$12K Sell
867
-533
-38% -$11.3K ﹤0.01% 1687
2019
Q4 		$38K Buy
1,400
+300
+27% +$8.25K ﹤0.01% 1214
2019
Q3 		$31K Buy
+1,100
New +$32.1K ﹤0.01% 1106

Other funds holding MYGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Rockefeller Capital Management's MYGN Position: Q2 2026 in Review

Rockefeller Capital Management reduced its Myriad Genetics (MYGN) stake by 73% in Q2 2026, selling an estimated $10.4K and leaving 838 shares worth $4.79K. The position accounts for ﹤0.01% of the portfolio, ranked #4254.

Rockefeller Capital Management first reported a position in MYGN in Q3 2019 and has held it in 18 quarters since. The position peaked at $39K in Q3 2021. 196 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

  • Rockefeller Capital Management held 838 shares of Myriad Genetics worth $4.79K as of Q2 2026.
  • Rockefeller Capital Management sold 2,285 Myriad Genetics shares in Q2 2026, an estimated $10.4K.
  • Myriad Genetics made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #4254 holding.
  • Rockefeller Capital Management first reported a position in Myriad Genetics in Q3 2019 and has held it in 18 quarters since.
  • Rockefeller Capital Management's Myriad Genetics position peaked at $39K in Q3 2021.
  • 196 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.